Please check your internet connection and try again.
# Arsil-DX (Dextromethorphan HBr / Guaifenesin)
## Overview
Arsil-DX is a fixed-dose combination product containing an antitussive (dextromethorphan) and an expectorant (guaifenesin). It is designed to suppress non-productive cough while thinning bronchial secretions to facilitate expectoration.
## Primary Indications
Symptomatic relief of cough due to minor throat and bronchial irritation associated with the common cold or inhaled irritants.
## Adult Dosing
* **Standard Dose:** 10–20 mg (dextromethorphan) / 200–400 mg (guaifenesin) every 4 hours, or 30 mg / 600 mg every 6–8 hours.
* **Maximum Dose:** 120 mg (dextromethorphan) / 2400 mg (guaifenesin) per 24 hours.
## Pediatric Dosing
* **Children 6–12 years:** 5–10 mg (dextromethorphan) / 100–200 mg (guaifenesin) every 4 hours. Maximum: 60 mg (dextromethorphan) / 1200 mg (guaifenesin) per 24 hours.
* **Children <6 years:** Not recommended without direct supervision of a pediatrician. Many professional organizations advise against OTC cough/cold products in children <4 years due to lack of efficacy and safety concerns.
## Dose Adjustments
* **Renal/Hepatic Impairment:** No formal adjustments provided by labels; however, caution is advised as accumulation of metabolites may occur. Use lower end of dosing frequency in severe impairment.
## Contraindications
* Hypersensitivity to dextromethorphan, guaifenesin, or any component of the formulation.
* Concomitant use with Monoamine Oxidase Inhibitors (MAOIs) or within 14 days of stopping an MAOI (risk of serotonin syndrome).
* Chronic/persistent cough (e.g., asthma, emphysema, smoking) unless directed by a physician.
## Adverse Effects
* **Common:** Dizziness, drowsiness, nausea, stomach pain, vomiting.
* **Serious:** Serotonin syndrome (if combined with serotonergic agents), psychiatric effects at supratherapeutic doses (hallucinations, dissociation).
## Key Drug Interactions
* **MAOIs:** Absolute contraindication due to risk of hypertensive crisis and serotonin syndrome.
* **SSRIs/SNRIs:** Increased risk of serotonin syndrome.
* **CNS Depressants (Alcohol, Opioids, Sedatives):** Potentiates sedative effects.
* **CYP2D6 Inhibitors:** May increase dextromethorphan concentrations.
## Monitoring
* Monitor for symptom resolution and duration of use (usually not recommended for >7 days).
* Assess for paradoxical excitation or excessive sedation.
* Monitor for signs of misuse/abuse (dextromethorphan is a known drug of abuse).
## Clinical Pearls
* **Hydration:** Emphasize fluid intake to support the mucolytic action of guaifenesin.
* **Product Selection:** Always verify the concentration and presence of additional ingredients (e.g., decongestants, antihistamines) as "DX" formulations vary by brand.
* **Caution:** Do not use for persistent or chronic cough (e.g., associated with smoking, asthma, emphysema, or where cough is accompanied by excessive phlegm).
***
**Educational Disclaimer:** This information is for educational purposes only. Always consult current prescribing information, local clinical protocols, and pharmacy databases (e.g., Lexicomp, Micromedex) before prescribing or administering medication. Confirm specific clinical guidelines with your institutional formulary.
